Form 4: Pacific Biosciences Officer Sells Shares to Cover Tax Obligations

Jeff Eidel, Chief Commercial Officer of Pacific Biosciences, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On August 19, 2024, Jeff Eidel, the Chief Commercial Officer of Pacific Biosciences, sold 26,760 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $1.592, with individual prices ranging from $1.58 to $1.63 per share.
• Following the transaction, Eidel directly owns 869,730 shares and indirectly owns 208 shares through his spouse.
• Eidel also purchased 3,128 shares on March 1, 2024, under the company's 2010 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be a routine sale to cover tax obligations, with no indication of a change in the officer's overall confidence in the company.

Industry Context

This is a routine Form 4 filing, which is common for corporate officers who sell shares, often to cover tax obligations related to stock vesting. It doesn't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale could have a minor negative impact on shareholders if it creates downward pressure on the stock price, although the volume is relatively small.

Key Dates